Literature DB >> 17936934

Genetic variability in the cytochrome P450-paraoxonase 1 (PON1) pathway for detoxication of organophosphorus compounds.

Clement E Furlong1.   

Abstract

Detoxication of organophosphorus (OP) compounds is affected by genetic and environmental modulation of a number of enzymes involved in the process. For organophosphorothioate insecticides, different P450 isozymes and variants carry out two reactions that have quite different consequences; (1) they bioactivate their parent compounds to highly toxic oxon forms that are many times more toxic than the parent compounds, and (2) concurrently, they dearylate the parent OP compounds, generating much less toxic metabolites. The ratios at which these different P450s carry out bioactivation versus dearylation differ among the P450 isozymes. The detoxication of the oxon forms of diazinon and chlorpyrifos is achieved by hydrolysis to the respective aromatic alcohols and diethyl phosphates primarily by paraoxonase 1 (PON1), a plasma enzyme tightly associated with high-density lipoprotein particles and also found in liver. Stoichiometric binding to other targets also contributes to the detoxication of these oxons. PON1 is polymorphically distributed in human populations with an amino acid substitution (Gln/Arg) at position 192 of this 354-amino acid protein (the initiator Met residue is cleaved on maturation) that determines the catalytic efficiency of hydrolysis of some substrates. In addition to the variable catalytic efficiency determined by the position 192 amino acid, protein levels of PON1 vary by as much as 15-fold among individuals with the same PON1(192) genotype (Q/Q; Q/R; R/R). The generation of PON1 null mice and transgenic mice, expressing each of the human PON1(192) alloforms in place of mouse PON1, has allowed for the examination of the physiological function of the PON1(192) alloforms in OP detoxication. Sensitivity to diazoxon exposure is primarily determined by the plasma level of PON1, whereas for chlorpyrifos oxon exposure, both the plasma PON1 level and the position 192 amino acid are important--PON1(R192) is more efficient in inactivating chlorpyrifos oxon than is PON1(Q192). The availability of PON1 null mice provides an opportunity to examine the contribution of other enzymes in the OP detoxication pathways without PON1 interference.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17936934     DOI: 10.1002/jbt.20181

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  14 in total

1.  Paraoxonase 1 (PON1) modulates the toxicity of mixed organophosphorus compounds.

Authors:  Karen L Jansen; Toby B Cole; Sarah S Park; Clement E Furlong; Lucio G Costa
Journal:  Toxicol Appl Pharmacol       Date:  2009-02-09       Impact factor: 4.219

2.  Reprogramming cells from Gulf War veterans into neurons to study Gulf War illness.

Authors:  Liang Qiang; Anand N Rao; Gustavo Mostoslavsky; Marianne F James; Nicole Comfort; Kimberly Sullivan; Peter W Baas
Journal:  Neurology       Date:  2017-05-16       Impact factor: 9.910

3.  Preanalytical variables affecting the measurement of serum paraoxonase-1 activity in horses.

Authors:  Gabriele Rossi; Amy Richardson; Hali Jamaludin; Cristy Secombe
Journal:  J Vet Diagn Invest       Date:  2020-11-22       Impact factor: 1.279

Review 4.  The toxicity of mixtures of specific organophosphate compounds is modulated by paraoxonase 1 status.

Authors:  Toby B Cole; Karen Jansen; Sarah Park; Wan-Fen Li; Clement E Furlong; Lucio G Costa
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

5.  Prenatal organophosphorus pesticide exposure and executive function in preschool-aged children in the Norwegian Mother, Father and Child Cohort Study (MoBa).

Authors:  Jake E Thistle; Amanda Ramos; Kyle R Roell; Giehae Choi; Cherrel K Manley; Amber M Hall; Gro D Villanger; Enrique Cequier; Amrit K Sakhi; Cathrine Thomsen; Pål Zeiner; Ted Reichborn-Kjennerud; Kristin R Øvergaard; Amy Herring; Heidi Aase; Stephanie M Engel
Journal:  Environ Res       Date:  2022-05-22       Impact factor: 8.431

6.  Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients.

Authors:  Fazile Hatipoglu Erdem; Saliha Karatay; Kadir Yildirim; Ahmet Kiziltunc
Journal:  Clinics (Sao Paulo)       Date:  2010-02       Impact factor: 2.365

7.  Serum lactonase and arylesterase activities in alcoholic hepatitis and hepatitis B.

Authors:  Mukund Ramchandra Mogarekar; Swati Jitendra Talekar
Journal:  Indian J Gastroenterol       Date:  2013-05-23

8.  A common mutation in paraoxonase-2 results in impaired lactonase activity.

Authors:  David A Stoltz; Egon A Ozer; Thomas J Recker; Miriam Estin; Xia Yang; Diana M Shih; Aldons J Lusis; Joseph Zabner
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

9.  Childhood brain tumors, residential insecticide exposure, and pesticide metabolism genes.

Authors:  Susan Searles Nielsen; Roberta McKean-Cowdin; Federico M Farin; Elizabeth A Holly; Susan Preston-Martin; Beth A Mueller
Journal:  Environ Health Perspect       Date:  2010-01       Impact factor: 9.031

10.  Paraoxonase 2 deficiency in mice alters motor behavior and causes region-specific transcript changes in the brain.

Authors:  Jacqueline M Garrick; Toby B Cole; Theo K Bammler; James W MacDonald; Judit Marsillach; Clement E Furlong; Lucio G Costa
Journal:  Neurotoxicol Teratol       Date:  2021-07-01       Impact factor: 4.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.